The purpose of this funding opportunity announcement (FOA) is to support studies that advance medical product development of interventions intended to prevent, diagnose, mitigate, treat, or cure ALS and other rare neurodegenerative diseases in adults and children. Through the support of these studies, FDA expects to address critical knowledge gaps, exert a significant impact on rare neurodegenerative diseases, and to inform current or future product development.  

Miscellaneous

• Unrestricted

Government

• State governments
• City or township governments
• Public and Indian housing authorities
• County governments
• Special district governments
• Federally recognized Native American tribal governments

Education

• Independent school districts
• Private institutions of higher education
• Public and state institutions of higher education

Nonprofit

• Nonprofits non-higher education with 501(c)(3)
• Nonprofits non-higher education without 501(c)(3)
• Other Native American tribal organizations

Business

• Small businesses
• For-profit organizations other than small businesses